Distinguishing Sedation From Efficacy In Antipsychotic Treatment
Agitation is frequently seen in patients with schizophrenia. When treating acute agitation in these patients, minimizing sedation should be a goal. During this webinar, Steven Szabo Jr, MD, Staff Psychiatrist, Durham Veterans Affairs Medical Center/Assistant Professor, Duke University Medical Center, Durham, NC and John Chelf, MD, Psychiatrist, Jack C. Montgomery Veterans Affairs Medical Center, Muskogee, OK, discuss how to recognize the symptoms of acute agitation in an emergency department setting, the potential importance of minimizing sedation in the treatment of …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.